Correlation Between Cingulate Warrants and Fortress Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Fortress Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Fortress Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and Fortress Biotech, you can compare the effects of market volatilities on Cingulate Warrants and Fortress Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Fortress Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Fortress Biotech.

Diversification Opportunities for Cingulate Warrants and Fortress Biotech

-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between Cingulate and Fortress is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Fortress Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fortress Biotech and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Fortress Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fortress Biotech has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Fortress Biotech go up and down completely randomly.

Pair Corralation between Cingulate Warrants and Fortress Biotech

Assuming the 90 days horizon Cingulate Warrants is expected to under-perform the Fortress Biotech. In addition to that, Cingulate Warrants is 2.99 times more volatile than Fortress Biotech. It trades about -0.02 of its total potential returns per unit of risk. Fortress Biotech is currently generating about 0.17 per unit of volatility. If you would invest  170.00  in Fortress Biotech on September 13, 2024 and sell it today you would earn a total of  36.00  from holding Fortress Biotech or generate 21.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.24%
ValuesDaily Returns

Cingulate Warrants  vs.  Fortress Biotech

 Performance 
       Timeline  
Cingulate Warrants 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cingulate Warrants has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable technical and fundamental indicators, Cingulate Warrants is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Fortress Biotech 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Fortress Biotech are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating forward indicators, Fortress Biotech displayed solid returns over the last few months and may actually be approaching a breakup point.

Cingulate Warrants and Fortress Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cingulate Warrants and Fortress Biotech

The main advantage of trading using opposite Cingulate Warrants and Fortress Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Fortress Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fortress Biotech will offset losses from the drop in Fortress Biotech's long position.
The idea behind Cingulate Warrants and Fortress Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios